Roche Venture Fund News Archive

image of several trees in a park

News archive

COUR Pharmaceuticals Secures $105 Million in Series A Financing
January 30, 2024

RVF participates in Mironid's Funding Round
September 13, 2023

DiogenX raises EUR27.5M Series A financing
May 10, 2023

Germany-based company acquires lino Biotech
March 16, 2023

Enliven Therapeutics Closes Merger with Imara and Private Placement of USD161 Million
February 23, 2023

Bionano Genomics to Acquire Purigen Biosystems
November 28, 2022

Bonum Therapeutics Announces a $93M Series Financing to Advance a Novel and Validated Class of Conditionally Active Therapies
November 15, 2022

Roche acquires Good Therapeutics to complement next generation PD1-IL2 therapeutics
September 7, 2022

Jasper Therapeutics Closes Transaction With Amplitude Healthcare Creating a Publicly Traded Biotechnology Company
April 21, 2022

Roche Venture Fund invests in the seed financing of Thelium Therapeutics
April 19, 2022

GlycoEra AG announced today the close of a CHF 45 million ($49 million) Series A financing round
November 5, 2021

Entrada Therapeutics Announces Closing of Initial Public Offering
November 2, 2021

Jasper Therapeutics Closes Transaction With Amplitude Healthcare Creating a Publicly Traded Biotechnology Company
September 24, 2021

Tango Therapeutics, Inc.closes merger with BCTG Acquisition Corp
August 10, 2021

Tempest Closes Merger with Millendo and Completes PIPE Financing
June 28, 2021

23andMe Successfully Closes its Business Combination with VG Acquisition Corp.
June 16, 2021

Centessa Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional ADSs
June 4, 2021

Soteria Biotherapeutics launches with USD42 Million Series A Financing led by Roche Venture Fund and 5AM Ventures
May 17, 2021

Jasper Therapeutics and Amplitude Healthcare Acquisition Corporation Announce Merger to Create a Publicly Listed Leading Biotechnology Company in Hematopoietic Stem Cell Transplantation
May 6, 2021

Eloxx Pharmaceuticals Acquires Zikani Therapeutics
April 1, 2021

Merck Completes Acquisition of Pandion Therapeutics
April 1, 2021

Tempest and Millendo Announce Proposed Merger Agreement
March 29, 2021

Enthera Pharmaceuticals extends Series A financing, raising a total of €35 million
January 28, 2021

Enliven Therapeutics Launches With Vision Of Advancing Medicine And Restoring Lives
December 7, 2020

Aligos Therapeutics announces Pricing of Initial Public Offering
October 15, 2020

C4 Therapeutics announces Pricing of an Upsized Initial Public Offering
October 1, 2020

Palladio Biosciences completes USD20 Million Series B Financing
September 25, 2020

BCTG Acquisition Corp. Announces Pricing of Upsized $145 Million Initial Public Offering
September 3, 2020

Vaxcyte Announces Pricing of Upsized Initial Public Offering
June 11, 2020

Roche acquires Stratos Genomics to further develop DNA based sequencing for diagnostic use
May 22, 2020

Jasper Therapeutics Announces Expansion of Series A Financing, Bringing Total Corporate Fundraising to More than $50 Million
January 9, 2020

Roche enters licensing agreement with Sarepta Therapeutics to improve the lives of patients living with Duchenne muscular dystrophy
December 23, 2019

Black Diamond Therapeutics Closes $85 Million Series C Financing
December 5, 2019

Purigen Biosystems Raises $26.4 Million Series B Financing to Accelerate Commercialization of Automated Sample Preparation Platform
November 11, 2019

NewLink Genetics and Lumos Pharma Enter into Merger Agreement to Form Biopharmaceutical Company Focused on Developing Therapies to Treat Rare Diseases
October 1, 2019

Allakos Announces AK002 Met All Prespecified Primary and Secondary Endpoints in Phase 2 Randomized, Double-Blind, Placebo-Controlled Study in Patients with Eosinophilic Gastritis (EG) and/or Eosinophilic Gastroenteritis (EGE)
August 5, 2019

Freenome Closes $160 Million Series B Financing to Advance Its Multiomics Blood Testing Platform for Early Cancer Detection
July 24, 2019

IDEAYA Announces Pricing of Initial Public Offering
May 22, 2019

Arch Oncology Raises $50 Million Series B Financing
March 25, 2019

Pfizer Secures Exclusive Option to Acquire Gene Therapy Company Vivet Therapeutics
March 20, 2019

Entrada Therapeutics Raises $59 Million Series A to Advance Intracellular Biologics Platform
December 18, 2018

Allakos announces Pricing of Initial Public Offering
July 19, 2018

Roche joins Intel & iSeed as investors in Care Innovations to expand its integrated diabetes management solutions with mySugr
June 25, 018

NMD Pharma raises €38M (~USD 47 Million) SERIES A Financing. Inkef Capital and Roche Venture Fund join investor syndicate
March 23, 2018

IDEAYA Biosciences Raises $94 Million Crossover Series B Financing
March 15, 2018

Pandion Therapeutics Announces $58 Million Series A Financing to Advance Tissue-Specific Immune Modulator Drugs for Autoimmune and Inflammatory Diseases
January 18, 2018

Syapse Enters Strategic Collaboration with Roche to Advance Precision Medicine in Oncology
January 9, 2018

mySugr joins the Roche Family
July 30, 2017

Aileron Therapeutics Announces Pricing of Initial Public Offering
June 29, 2017

Senseonics Announces Pricing of $41 Million Underwritten Offering of Common Stock
May 26, 2017

Vivet Therapeutics raises €37.5 million in Series A financing round to advance novel gene therapies for treating inherited metabolic diseases
May 4, 2017

CiVi Biopharma Receives Worldwide Exclusive License to Develop a Novel, RNA Targeted Drug Against PCSK-9
January 5, 2017

Tioma Therapeutics Announces $86 Million Series A Financing
August 16, 2016

Viewics Secures $10.5 Million in Capital, Closes Funding to Bring Advanced Analytics to Healthcare
August 3, 2016

Omicia Raises $23 Million in Series B Funding
June 8, 2016

Purigen Biosystems Receives $18.2M in Series A Financing led by 5AM Ventures and Roche Venture Fund
May 17, 2016

Second Genome Secures $42.6 Million in Series B Financing Led by Pfizer Venture Investments and Roche Venture Fund
April 20, 2016

Lumos Pharma raises $34 million in Series B financing
April 6, 2016